What is the fate of Kinder Morgan, Inc. (KMI) against Teva Pharmaceutical Industries Limited (TEVA)?

The shares of Kinder Morgan, Inc. (NYSE:KMI) and Teva Pharmaceutical Industries Limited (NYSE:TEVA) were among the active stocks of the last trading sessions. Kinder Morgan, Inc. (NYSE:KMI) soared to 1.1% closing at the price of $17.45 whereas the shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA) soared 1.05% with the increase of 0.24 points closing at the price of $23.09. Kinder Morgan, Inc. has currently increase 6.08% in its stock over the period of 6-months while its rival Teva Pharmaceutical Industries Limited added 19.45% in the previous 6-months.

Now we have to analyze the facts that if the stocks were worthy off investors’ money? The facts to analyze here are risks, profitability, returns and price trends.

Returns and Profitability

Profitability and returns are the main reason of investment, the investors are looking for profits that they get and return they should expect over the period of time.

The first and foremost return that is considered while making an investment is the ROI or Return on Investment. The ROI is the ratio between the profit against the cost of investment. Currently the ROI of Kinder Morgan, Inc. (NYSE:KMI) is 0.3% while the ROI of Teva Pharmaceutical Industries Limited (NYSE:TEVA) is -36%. Another figure that is to be considered while analyzing the profitability of a share is its EBITDA margin, KMI’s EBITDA Margin is 12.57 whereas TEVA’s is 10.03.

Both the profitability ratios suggest that Kinder Morgan, Inc. (NYSE:KMI) is more suitable investment in terms of profitability and return.

EPS & Surprise Factor

Kinder Morgan, Inc. (NYSE:KMI) reported $0.22/share EPS for the previous quarter where analysts were predicting an EPS to be $0.21/share Thus beating the analyst Estimates with a Surprise Factor of 4.8 Percent. While, Teva Pharmaceutical Industries Limited (NYSE:TEVA) reported EPS of $0.68/share in the last quarter. The analysts projected EPS of $0.54/share depicting a Surprise of 25.9 Percent.

Taking a look at Earnings per Share, Teva Pharmaceutical Industries Limited tends to be beating the analyst estimates more than Kinder Morgan, Inc.. so TEVA is more profitable than KMI.

Technical Analysis of Kinder Morgan, Inc. & Teva Pharmaceutical Industries Limited

Moving average convergence divergence (MACD) shows that Kinder Morgan, Inc. (NYSE:KMI) is on a PRICE RELATIVITY trend While Teva Pharmaceutical Industries Limited (NYSE:TEVA) is on PRICE RELATIVITY trend. The trend for the past 10-days shows that the Kinder Morgan, Inc. was in BULLISH territory and Teva Pharmaceutical Industries Limited was in BULLISH territory.

KMI’s current statistics gauge that the stock candle is BULLISH with HIGH volatility. While TEVA’s candle is BEARISH with HIGH.

EPS Growth Rate: KMI’s 12% versus TEVA’s -7.49%

Another shareholder value can be analyzed through the EPS growth rate; the next 5 years EPS growth rate is predicted by the analysts after the analyzing the previous trends. The next 5 year EPS growth rate of Kinder Morgan, Inc. (NYSE:KMI) is predicted at 12% while Teva Pharmaceutical Industries Limited (NYSE:TEVA) stands at -7.49%. These numbers suggest that KMI is more suitable investment in terms of EPS growth rate.

Financial Risk and Liquidity Concerns

The current ratio and the debt ratio are the two ratios that show the investor how quickly the company is able to payout its debt and how quickly it can cover its obligations. The current ratio of KMI stands at 1.1 while TEVA is at 1 whereas the debt ratio of the prior is 1.12 while the debt ratio of the later is 2.13.

The values of the both ratios suggest that one is more liquid and other investment is more risk free.

Analyst Recommendations

While making an investment, another main factor to consider before investing is the analyst recommendation on the scale of 1 to 5 where 1 is strong buy, 2 is buy, 3 is hold, 4 is Sell and 5 is strong sell. Analyst recommend 1.8 for KMI and 2.9 for TEVA which means KMI has Buy rating whereas TEVA has Hold rating.

Another recommendation of analyst that is to be considered worthy is the price target. The mare price or price trend does not suggest the suitability of a stock. The price target set by analyst is also to be considered while investing as it suggests to what extent the stock will rise or fall in the near future. The price target set for KMI is $21.79 which is 19.92% of its current price while TEVA has price target of 21.22 which is -8.81% of its current price.

Valuation Ratios

Valuation is the process of determining the company’s worth for an investor, the valuation ratios give an insight to that worthiness.

KMI currently has price to earning P/E ratio of 0 whereas TEVA has 0 while the forward P/E ratio for the prior stands at 16.81 and for the later it depicts the value of 8.21.

The price to Book P/B for KMI is 1.15, Price to Sale is at 2.8 and for TEVA these ratios stand at 1.66 and 1.16.